Feng, T.; Jiang, L.; Zhuang, J.; Cai, L.; Yang, X.; Yu, H.; Yang, H.; Lu, Q.
PD-L1+ CTCs Are Associated with Adverse Pathological Features and Unfavorable Prognosis in Bladder Cancer. Diagnostics 2026, 16, 1776.
https://doi.org/10.3390/diagnostics16121776
AMA Style
Feng T, Jiang L, Zhuang J, Cai L, Yang X, Yu H, Yang H, Lu Q.
PD-L1+ CTCs Are Associated with Adverse Pathological Features and Unfavorable Prognosis in Bladder Cancer. Diagnostics. 2026; 16(12):1776.
https://doi.org/10.3390/diagnostics16121776
Chicago/Turabian Style
Feng, Tianshuo, Linjing Jiang, Juntao Zhuang, Lingkai Cai, Xiao Yang, Hao Yu, Haiwei Yang, and Qiang Lu.
2026. "PD-L1+ CTCs Are Associated with Adverse Pathological Features and Unfavorable Prognosis in Bladder Cancer" Diagnostics 16, no. 12: 1776.
https://doi.org/10.3390/diagnostics16121776
APA Style
Feng, T., Jiang, L., Zhuang, J., Cai, L., Yang, X., Yu, H., Yang, H., & Lu, Q.
(2026). PD-L1+ CTCs Are Associated with Adverse Pathological Features and Unfavorable Prognosis in Bladder Cancer. Diagnostics, 16(12), 1776.
https://doi.org/10.3390/diagnostics16121776